Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Dr. Oz signals support for more automatic Medicare coverage of medtech; FDA staffers face space and other challenges in their return to in-person work; China NMPA advances policies for domestic manufacturing and clinical trial oversight; MedTech Europe’s regulatory advocacy; and more.
An Israeli start-up’s clever method for making gold-standard neuromodulation therapy more accessible gives patients the power to learn to regulate brain activity associated with PTSD.
Probationary CDRH staff called back, but more layoffs could be coming. Excerpted from Pathways’ Picks February 26: CDRH Staff Called Back, But More Cuts Might Come, eIFUs in the EU, and Global Picks.